Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus vs IVIG in Acute Rasmussen Encephalitis
NCT00545493Phase 3Unknown
- Sponsor
- University Hospital Bonn
- Start
- Nov 2002
- Primary completion
- Apr 2010
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tacrolimus, polyvalent human immunoglobulin in Rasmussen encephalitis (RE), sponsored by University Hospital Bonn. Status: unknown.
02
Drugs
tacrolimuspolyvalent human immunoglobulin
03
Conditions
Rasmussen encephalitis (RE)
Beyond the preview
Go deeper on NCT00545493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00545493.